PenRad Technologies Competitors and Similar CompaniesClear all
PenRad Technologies's competitors and similar companies include Solos Endoscopy, PharmaCCX and DYSIS Medical.
 PenRad Technologies PenRad Technologies is a company that provides software for breast imaging and lung screening. |  Solos Endoscopy Solos Endoscopy is a medical device company that develops endoscopic instruments and medical imaging solutions. |  PharmaCCX PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market. |  DYSIS Medical DYSIS Medical is a medical device company that designs, develops, manufactures, and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. | |
Founding Date | Founding Date 1995 | Founding Date 1986 | Founding Date 2017 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Buffalo, US HQ | Locations Warrenton, US HQ Westport, US | Locations Boston, US HQ Stockholm, SE Zug, CH San Mateo, US | Locations Edinburgh, GB HQ Alpharetta, US |
Employees | Employees 10 | Employees N/A | Employees 558% increase | Employees 23 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3m (over 7 years ago) | Latest funding round $ 23.9m (about 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 88k | Total funding raised $ 3m | Total funding raised $ 35.5m |
For sources of this data, please see the company profile
View Company Profiles
Solos Endoscopy
HQ
Warrenton, US
Solos Endoscopy is a medical device company that develops endoscopic instruments and medical imaging solutions.
View companyPharmaCCX
HQ
Boston, US
Employees
55↑ 8% increase
PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market.
View companyDYSIS Medical
HQ
Edinburgh, GB
Employees
23
DYSIS Medical is a medical device company that designs, develops, manufactures, and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.
View company